Expert Interview
Examining the results of the Phase 3 ATTRibute-CM study of acoramidis in ATTR-CM by BridgeBio Pharma presented at International Symposium of Amyloidosis (ISA)
Ticker(s): BBIOInstitution: UC Irvine
- Cardiologist at UC Irvine with a focus on cardiomyopathies.
- Currently treats 150 patients with Hypertrophic Cardiomyopathy.
- Published at the AHA and ISHLT with regards to advanced cardiomyopathies as well as mechanical circulatory support.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
